Allogeneic double‐negative T cells as a novel adoptive cellular immunotherapy for relapsed AML post allo‐HSCT : a first‐in‐human phase I study
American Journal of Hematology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要